Brian Kevin Park

589 citations
12 papers · 378 indexed · h-index 12
Topics
Drug-Induced Adverse Reactions (3 papers)Pharmacogenetics and Drug Metabolism (3 papers)Drug Transport and Resistance Mechanisms (2 papers)

In The Last Decade

Brian Kevin Park

12 papers receiving 364 citations

Peers

Brian Kevin Park
Comparison fields: 5 of 76
  • Pharmacology 129
  • Pharmacology 102
  • Molecular Biology 63
  • Biomedical Engineering 59
  • Dermatology 52
Replace Shinji Kobuchi with:
Shinji Kobuchi Japan
Archie Thurston United States
Xu Zhu China
Thomas Emm United States
Amy Sharma United States
Monish Jain United States
Zuojun Li China
Caroline J. Earnshaw United Kingdom
Arun Tailor United Kingdom
Wen Xiao China
Brian Kevin Park relative to Shinji Kobuchi Japan Shinji Kobuchi's profile →
Citations per field
00.5×1.5×2.2×
Shinji Kobuchi · 1×
Citations per year

Countries citing papers authored by Brian Kevin Park

Since Specialization
Citations

This map shows the geographic impact of Brian Kevin Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Kevin Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Kevin Park more than expected).

Fields of papers citing papers by Brian Kevin Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Kevin Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Kevin Park. The network helps show where Brian Kevin Park may publish in the future.

Co-authorship network of co-authors of Brian Kevin Park

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Kevin Park. A scholar is included among the top collaborators of Brian Kevin Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Kevin Park. Brian Kevin Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 16
2 26
3 11
4 30
5 68
6 15
7 55
8 39
9 40
10 12
11 50
12 16

About Brian Kevin Park

Brian Kevin Park is a scholar working on Pharmacology, Pharmacology and Immunology, having authored 12 papers that have together received 378 indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Pharmacology (129 citations), Pharmacology (102 citations) and Dermatology (52 citations). Brian Kevin Park has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Dean J. Naisbitt, Munir Pirmohamed, Sidonie N. Lavergne, Cheng‐Hong Toh, Andrea Jorgensen, Paula Williamson, Ana Alfirevic, Andrew Gibson, John Farrell and Marie Held. Their work appears in journals such as ACS Nano, Journal of Investigative Dermatology and Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026